IRCT20230318057749N1已完成2 期
The effect of Silymarin on the level of lipid profile and fasting blood sugar and HbA1c in patients with type 2 diabetes.
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 68 years(—)
- 性别
- All
入选标准
- •Patients with type 2 diabetes referring to the clinic of the Endocrine Research Institute of Iran University of Medical Sciences
- •Age group 30-68 years
- •Fasting plasma sugar more than 126 mg/dl
- •Duration of the onset of the disease more than 2 years
排除标准
- •Pregnant and lactating women
- •People less than 30 years old
- •Following a special diet
- •Suffering from cardiovascular disease, infectious diseases, kidney disease, thyroid disease
- •Treatment with Sealy Marine in 30 days before the study
- •Using chemical drugs and herbal supplements and nutritional supplements
- •Insulin therapy
研究者
相似试验
已完成
1 期
Evaluation of the effect of silymarin on cholesterol triglyceride and BMI in patients with type 2 diabetes mellitus referring to endocrine clinic of Imam khomeini hospital UrmiaBMI and Lipid profile in type 2 DM.R4IRCT20170814035697N4Oroumia University of Medical Sciences50
已完成
4 期
The effect of silymarin on Alzheimer’s diseasesAlzheimer disease.Alzheimer's diseaseIRCT20131219015870N3Faculty of Pharmaceutical Sciences, Islamic Azad University of Medical Sciences, Tehran22
已完成
1 期
Evaluation of the effect of silymarin on blood sugar profile(FBSand 2hpp ) and HbA1C in patients with type 2 diabetes mellitusIRCT20170814035697N5Oroumia University of Medical Sciences50
已完成
不适用
Effects of sitagliptin and sulfonylurea on lipid and glucose metabolism in patients with type 2 diabetes fairly or poorly controlled with oral agents including sulfonylurea : a prospective randomized, multicenter, open-label trialType 2 diabetesJPRN-UMIN000006511Glucose and Lipid metabolism conference200
已完成
不适用
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugsDrug induced hepatitis by anti tuberculosis.Antimycobacterial drugsIRCT138903294209N1ational Institute of tuberculosis and lung disease60
